Skip to main content

The Barancik Prize for Innovation in Multiple Sclerosis Research was recently awarded to University of California professor Katerina Akassoglou, Ph.D. for her work understanding the origins of nerve damage in MS and identifying potential therapies to prevent it.

The Barancik Prize was established by the Charles & Margery Barancik Foundation to inspire original ideas in stopping the disease. The most prestigious of its kind in the MS scientific community, the annual award comes with $100,000 to be used at the discretion of the recipient. Akassoglou is the sixth recipient of the award.

“This award is game-changing,” says Teri A Hansen, President | CEO of the Barancik Foundation.  “For most researchers, acclaim of this level comes at the end of their tenure. The Barancik Prize is aimed to recognize up and coming leaders in MS research and incentivize breakthroughs.”

Because MS affects a small percentage of the US population, research on the disease receives little to no federal funding. The Barancik family have been moved to support efforts to end MS for decades, because of a loved one afflicted with the condition. Most people with multiple sclerosis are diagnosed between the ages of 20 and 50, and it affects women three times more often than men.

The international prize is administered through the National MS Society.

About Barancik Foundation

The Charles and Margery Barancik family has long believed in the power of philanthropy to shape our world and enrich the lives of all people. It was the expression of this belief that led them in 2014 to establish Charles & Margery Barancik Foundation—a private, family foundation located in Sarasota, Florida.

1515 Ringling Boulevard, Suite 500, Sarasota FL 34236
The Barancik Foundation does not accept unsolicited requests for funding.

©2020 Charles & Margery Barancik Foundation. All rights reserved.